Your ideal treatment depends on your subtype of breast cancer.
Today, treatment for metastatic breast cancer (or breast cancer that has spread to other parts of the body) involves more than just the traditional chemotherapy. Options like hormone therapy, targeted therapy, and immunotherapy now play major roles in breast cancer treatment.
However, chemotherapy has not disappeared. It’s still frequently used in conjunction with other therapies (to make them even more effective), or in cases where a patient simply isn’t eligible for the newer treatment options.
“There are many different types of treatment available for metastatic breast cancer, and those treatments really depend on your subtype of breast cancer,” says Natalie Berger, MD, hematologist and oncologist at The Mount Sinai Hospital. “While you may hear that somebody you know had X treatment, that one may not pertain to you because you have a different subtype of breast cancer.”
How Do You Know Your Eligibility?
When you are diagnosed with breast cancer, your doctor will tell you your stage and your subtype. Stages range from I to IV, which rates how much the cancer is affecting the body. The higher the stage, the larger the tumor and/or the more likely that the cancer has spread to lymph nodes or other organs.
Then there is breast cancer receptor status. This refers to tiny receptors on the surface of the cancer cell that help fuel the cancer growth. Breast cancer can have estrogen or progesterone receptors (hormone receptor-positive breast cancer), receptors for the growth-promoting protein HER2/neu (HER2-positive breast cancer), or they may contain neither of these three receptors (triple-negative breast cancer).
“The reason we look for these receptors is because we have specific therapies that target these,” says Dr. Berger.
For example, hormone receptor-positive breast cancer can be effectively treated with hormone therapy. These medications either slow the production of hormones by the body, or inhibit the hormones from interacting with the receptors, which slows or stops the growth of these tumors.
HER2-positive breast cancer often uses targeted therapy, which specifically targets cells with HER2/neu receptors. Learn more about how targeted therapy treats breast cancer here.
Neither hormone therapy nor targeted therapy are appropriate for triple-negative breast cancer. This is often when chemotherapy plays a big role in treatment, along with immunotherapy in some cases. Find out how triple-negative breast cancer is treated here.
“Treatments for breast cancer have advanced rapidly over the last few years. Today, treatments are moving further and further away from our traditional chemotherapies, and more toward targeted therapies, personalized medicine, so that the side effects and the tolerability of these treatments are much better today than they were in the past,” says Dr. Berger.
Dr. Berger is a hematologist and oncologist at The Mount Sinai Hospital in New York City.
00:00:01.233 --> 00:00:03.332
00:00:03.333 --> 00:00:04.899
There are many different types of treatment available
00:00:04.900 --> 00:00:07.266
for metastatic breast cancer, and those treatments
00:00:07.267 --> 00:00:09.532
really depend on your subtype of breast cancer.
00:00:09.533 --> 00:00:12.099
So while you may hear that somebody you know had X treatment,
00:00:12.100 --> 00:00:14.099
that one may not pertain to you because you have a
00:00:14.100 --> 00:00:16.099
different subtype of breast cancer.
00:00:16.100 --> 00:00:23.732
00:00:23.733 --> 00:00:26.066
At the time of diagnosis of breast cancer, your doctor
00:00:26.067 --> 00:00:28.632
will recommend that you go for a biopsy.
00:00:28.633 --> 00:00:31.032
When the biopsy is performed, that tissue specimen
00:00:31.033 --> 00:00:33.132
will go to a pathologist who will look at that cancer
00:00:33.133 --> 00:00:34.532
under the microscope.
00:00:34.533 --> 00:00:36.899
When our pathologists look at the cancer under the microscope,
00:00:36.900 --> 00:00:38.866
they look for three important receptors,
00:00:38.867 --> 00:00:40.266
in addition to many other things.
00:00:40.267 --> 00:00:43.566
The subtypes of breast cancer are hormone receptor-positive
00:00:43.567 --> 00:00:46.066
breast cancer, which is the estrogen receptor
00:00:46.067 --> 00:00:48.199
and/or the progesterone receptor.
00:00:48.200 --> 00:00:50.666
There's also HER2-positive breast cancer,
00:00:50.667 --> 00:00:52.732
as well as triple-negative breast cancer,
00:00:52.733 --> 00:00:54.866
and what triple-negative breast cancer means is that
00:00:54.867 --> 00:00:57.332
the cancer cells don't express the estrogen receptor,
00:00:57.333 --> 00:00:59.999
the progesterone receptor, or the HER2 receptor.
00:01:00.000 --> 00:01:01.966
And the reason we look for these receptors is because
00:01:01.967 --> 00:01:04.532
we have specific therapies that target these.
00:01:04.533 --> 00:01:06.066
Often times the first line of treatment
00:01:06.067 --> 00:01:08.366
of hormone receptor-positive metastatic breast cancer
00:01:08.367 --> 00:01:10.866
is actually a pill form of treatment.
00:01:10.867 --> 00:01:13.232
It's a combination of two pills that you can use
00:01:13.233 --> 00:01:15.399
and take at home, and just follow up with your doctor
00:01:15.400 --> 00:01:17.566
for blood counts and toxicity checks.
00:01:17.567 --> 00:01:20.099
For HER2-positive breast cancer, the first-line therapy
00:01:20.100 --> 00:01:22.599
for metastatic breast cancer often involves a combination
00:01:22.600 --> 00:01:24.999
of chemotherapy with targeted therapies
00:01:25.000 --> 00:01:26.966
against the HER2 receptor itself.
00:01:26.967 --> 00:01:28.766
And often times for triple-negative, the first-line
00:01:28.767 --> 00:01:31.099
treatment will involve chemotherapy
00:01:31.100 --> 00:01:33.099
and it may also involve immunotherapy.
00:01:33.100 --> 00:01:35.632
I tell all of my patients that nobody is going to be
00:01:35.633 --> 00:01:37.499
a better advocate for you than yourself.
00:01:37.500 --> 00:01:39.899
Treatments for breast cancer have advanced rapidly
00:01:39.900 --> 00:01:41.366
over the last few years.
00:01:41.367 --> 00:01:44.299
Today, treatments are moving further and further away
00:01:44.300 --> 00:01:46.966
from our traditional chemotherapies, and more toward
00:01:46.967 --> 00:01:49.866
targeted therapies, personalized medicine,
00:01:49.867 --> 00:01:52.332
so that the side effects and the tolerability of these treatments
00:01:52.333 --> 00:01:55.499
are much better today than they were in the past.
00:01:55.500 --> 00:01:58.700
Breast cancer treatment (adult)(PDQR) - patient version. Bethesda, MD: National Cancer Institute. (Accessed on February 6, 2020 at https://www.cancer.gov/types/breast/patient/breast-treatment-pdq.)
Hormone therapy for breast cancer. Bethesda, MD: National Cancer Institute. (Accessed on February 6, 2020 at https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet.)Targeted therapy for breast cancer. Atlanta, GA: American Cancer Society. (Accessed on February 6, 2020 at https://www.cancer.org/cancer/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html.)